The standalone Q1 results are clearly bearish, but the imminent Vireo acquisition (expected to close imminently) means the stock price will track the deal terms, not the underlying operational weakness. Traders should monitor for the final court order and regulatory approvals to ensure the deal closes as scheduled on August 21, 2026.
Price Chart
Executive Summary
C21 Investments filed Q1 FY2027 results showing a significant operational deterioration: revenue fell 10.8% YoY to $7.6M, operating income swung from a $0.2M profit to a $1.2M loss, and net loss widened to $2.0M from $0.8M. The Nevada cannabis market is experiencing price compression and increased competition, with state-wide sales down over 12%. However, the company is in the process of being acquired by Vireo Growth Inc., with shareholder approval already obtained and closing expected on or about August 21, 2026, which largely mutes the standalone impact of these weak results for current shareholders.
Key Facts
- Revenue declined 10.8% YoY to $7.6M from $8.6M.
- Operating income swung to a loss of $1.2M from a profit of $0.2M.
- Net loss widened to $2.0M from $0.8M.
- Gross profit margin compressed to 32.5% from 34.9% YoY.
- Cash from operations improved to $0.8M from $0.5M.
- The Vireo acquisition (0.023052 Vireo shares per C21 share) is expected to close on or about August 21, 2026, after receiving 96.58% shareholder approval.
Financial Impact
Revenue down $0.9M YoY; operating income swing of -$1.4M; net loss increase of $1.2M.
Risk Factors
- Acquisition by Vireo may fail to close if regulatory or court approvals are not obtained.
- Continued price compression and competition in the Nevada cannabis market could further erode margins.
- The company carries a large uncertain tax position of $14.1M related to Section 280E.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001062993-26-004543 |
| Exhibit: exhibit99-2.htm | 0001062993-26-004543 |
| Exhibit: exhibit99-4.htm | 0001062993-26-004543 |
| Exhibit: exhibit99-3.htm | 0001062993-26-004543 |
| Document: form6k.htm | 0001062993-26-004543 |
| Document: 0001062993-26-004543-index-headers.html | 0001062993-26-004543 |
| Document: 0001062993-26-004543-index.html | 0001062993-26-004543 |
| Document: 0001062993-26-004543.txt | 0001062993-26-004543 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | 6-K | $0.2590 awaiting T+20 | awaiting T+20 | โ | โ |
Jun 15, 2026 15w ago | 6-K | $0.2490 $0.2390 | โผ โ4.02% | โผ โ3.88% | โ |
Jun 12, 2026 16w ago | 20-F | $0.2700 $0.2388 | โผ โ11.56% | โผ โ12.82% | โ |
Jun 12, 2026 16w ago | 6-K | $0.2700 $0.2388 | โผ โ11.56% | โผ โ12.82% | โ |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access